Position in RZLT
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$41,242
+$15,110 QoQ
Shares Held
13,522
+22.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HB Wealth Management, LLC holds $28,265,702 across 30 Biotechnology names. RZLT ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
50,237 | $8,491,057 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,287 | $4,593,556 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,436 | $2,654,791 | |
| 4 | TECH |
BIO-TECHNE Corp
|
34,140 | $1,784,156 | |
| 5 | EXEL |
Exelixis, Inc.
|
29,055 | $1,246,168 | |
| 6 | SABS |
SAB Biotherapeutics, Inc.
|
307,500 | $1,177,725 | |
| 7 | IMUX |
Immunic, Inc.
|
91,450 | $1,015,095 | |
| 8 | RPRX |
Royalty Pharma plc
|
18,229 | $874,445 |
All Filings in RZLT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,242 | 13,522 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $26,132 | 11,073 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||